drugset / Trial / NCT00387309
Study Evaluating IV Methylnaltrexone for the Treatment of Post Operative Ileus
RandomizedParallel-groupDouble-blindTreatment
Summary
Primary Objective: In subjects who have undergone segmental colectomy, the time between the end of surgery and first bowel movement is significantly shorter with the investigational MOA-728 regimen than with a placebo regimen.
Timeline
- Start
- 2006-12
- Primary completion
- —
- Completion
- 2007-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylnaltrexone | Other / unclassified | 12 mg | Intravenous |
| Subject | Methylnaltrexone | Other / unclassified | 24 mg | Intravenous |